O.08 ULTRA-DEEP TARGETED RESEQUENCING REVEALS RECURRENT DAXX AND CYFIP2 MUTATIONS AND IMPLICATES NOVEL PATHWAYS IN PANCREATIC NEUROENDOCRINE TUMORS

By: T. Vandamme MD, M. Beyens , G. Van Camp , G. Boons , L. Hofland , M. Peeters MD, PhD, K. Op de Beeck

To read the full artice you have the following options:

* (only possible for healthcare professionals with RIZIV/INAMI/MATRICULE working in the field of Oncology/Hemato-oncology in Belgium and Luxembourg with prescription authorisation)

Purchase this article for €2.42

** (for healthcare professionals with prescribing authorisation working outside the field of Oncology/Hemato-oncology in Belgium and Luxembourg as well as those without prescribing authorisation working as healthcare professional in Oncology/Hemato-oncology in Belgium and Luxembourg, plus persons without prescription authorisation working outside Belgium and Luxembourg, plus healthcare professionals with prescribing authorisation outside Belgium and Luxembourg plus non-healthcare professionals from outside or inside Belgium or Luxembourg)